What is “AF Burden”?. What is “AF Burden”? AF Burden and Stroke Risk ASSERT Study.

Slides:



Advertisements
Similar presentations
Atrial fibrillation and subcutaneous monitoring : Will it change our daily practice ? Aymeric MENET Lille January 2016.
Advertisements

R2. 최태웅 / Pf. 김진배. BACKGROUND  Ischemic stroke : leading causes of death and disability : cause remains unexplained after routine evaluation → Cryptogenic.
Upfront Combination Therapy vs Step-Up Approach for PAH:
Addressing the Challenges in Primary and Secondary Stroke Prevention
The Patient Experience With Systemic Lupus Erythematosus
Covering the Bases in Cardioversion
Silent No More:.
Burden of Atrial Fibrillation The Percentage of Strokes Attributable to AF Increases With Age.
Monitoring Continuum ISSUE-3 Atrial Fibrillation Classification.
Atrial Fibrillation and PCI
Starting Strong: Initial Evaluation of the Patient With HCV
New Data on the Safety of SGLT2 Inhibitors
US Guidelines US Guidelines Low-risk Patients.
NOACs, AF, and PCI: What Do the Latest Data Suggest?
When Is Adding Aspirin to NOACs Worth the Risk?
The ABCs of AF.
Does One Size Fit All in Obesity Management?
Access to NOAC Therapy:
NOACs in Clinical Practice: Are They All the Same?
Current Controversies in Multiple Sclerosis Management
A New Era for NOACs:.
Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.
Is Your Patient Engaged in Care
Statin Selection in Special Patient Populations: A Case Challenge
Antithrombotics and PAD: A New Paradigm in Practice
Oral Anticoagulants in AFa,b A Brief History.
Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?
Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.
Stroke and AF.
Assessing the Risk for Stroke in Patients With Atrial Fibrillation
Improving Risk Assessment and Early Diagnosis in PAH
Are We Closer to Personalized Medicine in MS?
Applying Real-World Evidence in Atrial Fibrillation Into Clinical Care:
Efficacy and Safety of Edoxaban in Patients With AF and HF
Advances in the Management of Severe and Life-Threatening Chemotoxicity.
AF and PCI in Practice.
Access to NOAC Therapy:
CoreValve US Pivotal Trial High-Risk Arm Device and Access Routes.
How to Optimize TAVR Outcomes
TAVR and the Risk of Thrombosis
What Anticoagulant Registries Are Revealing
A Hard Look at Cardiogenic Shock: IABP-SHOCK II Revisited
Oral Anticoagulation in AF
Mitral Valve Disease.
Nat. Rev. Cardiol. doi: /nrcardio
Atrial Fibrillation.
An Interprofessional Perspective on the Safe and Appropriate Use of Opioid Analgesics.
Taking the "Cryptogenic" Out of Cryptogenic Stroke
Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.
Identifying High-Risk AF Patients
Cost-effective Approaches to Diagnosing Syncope
Treatment-Resistant Schizophrenia
Optimizing Joint Health in Hemophilia
-.&- ·Af& Q 0 "i'/
PeaceHealth Southwest Hospital/Carson Tahoe Medical Center
The ABCs of AF.
Disease Burden of VTE Phases of VTE Treatment.
Taking the "Cryptogenic" Out of Cryptogenic Stroke
5 Good Minutes on Atrial Fibrillation-related Stroke
Nat. Rev. Cardiol. doi: /nrcardio
Real-World Data in Cardiology: Focus on Atrial Fibrillation
Figure 1 Novel markers of increased stroke risk in AF
Successful AF Ablation Outcomes
Expert Perspectives.
NAFLD and NASH in Europe and Canada
Rethinking Risk Stratification for Nonischemic HF:
Extraordinary Cases in Stroke Prevention
The Power of As-Treated Analyses
What's New in NOACs in AF?.
Treating Pulmonary Embolism Today
Presentation transcript:

What is “AF Burden”?

AF Burden and Stroke Risk ASSERT Study

AF Burden and Clinical Risk Assessment

AF Burden and Clinical Risk Assessment (cont)

Is There a Temporal Relationship Between AF and Stoke/TE?

DISCERN AF Trial

Implantable Cardiac Monitors to Detect AF

DISCERN AF Trial (cont)

Asymptomatic AF Detection Current Clinical Implications

Asymptomatic AF Detection Future Clinical Implications

AF and Stroke A Cause or a Marker?

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)